What to Expect From Colgate-Palmolive Company’s Q4 Results?
<p>Analysts at RBC Capital provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/CL'>Colgate-Palmolive Company (NYSE:CL) </a>ahead of Q4 results, expecting an organic sales growth of 3.2% (vs. Street’s 3.4%) and EPS of $0.80 (vs. Street’s $0.79). </p>
<p>The analysts expect Hill’s and emerging markets to continue driving the company’s top-line results, partially offset by softness in North America home care. </p>
<p>The analysts expect continued high inflationary cost pressure to continue into 2022, particularly in the first half. Additionally, the analysts mentioned that the company does not significantly hedge its commodity exposure, as highlighted by CFO Stan Sutula at Dec 1 conference.</p>
<p>The analysts expect the company to be a slight underperformer during earnings season, particularly relative to strong P&G results last week.</p>

NYSE:CL